Differentiating Diabetic Ketoacidosis and Hyperglycemic Ketosis Due to Cannabis Hyperemesis Syndrome in Adults With Type 1 Diabetes
Jabby Your GLP-1 Injection Tracking Companion Track doses
Inflammation Res
Comorbidities collected within 6 months before the index date included metabolic syndrome (hypertension and dyslipidemia), cardiovascular disorders (heart failure, myocardial infarction, ischemic stroke, peripheral arterial disease, coronary artery disease, cardiovascular disease [CVD]), and chronic kidney disease
Kambham, N., Markowitz, G
The developed model described busulfan PK IIV well, and model-based target attainment of different dosing strategies was evaluated